Zydus Cadila receives nod from Drug Controller General of India

“The novel biologic which will be marketed under the brand name, Twinrab, is indicated in combination with rabies vaccine for rabies post-exposure prophylaxis,” Zydus Cadila said in a statement. Continue Reading